The Janus Pharma Insights copertina

The Janus Pharma Insights

The Janus Pharma Insights

Di: Rohit Mehmi
Ascolta gratuitamente

The Janus Pharma Insights is a podcast by Janus Biotech focused on India’s evolving pharmaceutical and healthcare industry. From pharmaceutical manufacturing, PCD pharma franchise, and third-party manufacturing to skincare, nutraceuticals, healthcare innovation, and pharma business growth — this podcast explores the ideas, trends, and strategies shaping the future of the pharma sector.

Each episode brings practical discussions, industry insights, manufacturing knowledge, and healthcare business conversations designed for pharma professionals, distributors, healthcare entrepreneurs, and growing pharmaceutical brands.Powered by Janus Biotech, this podcast shares trusted pharmaceutical industry insights backed by years of experience in India’s healthcare and pharma manufacturing ecosystem.

Explore more at Janus Biotech.Janus Biotech Arte Cucina Enogastronomia Igiene e vita sana
Episodi
  • Vonoprazan HP Kit and Domperidone: The Gastro Combinations Worth Knowing

    Vonoprazan HP Kit and Domperidone: The Gastro Combinations Worth Knowing
    Jul 16 2026
    Episode 4. We go deeper into the Vonoprazan product range — covering two combinations that are gaining serious traction with doctors right now. The Vonoprazan HP kit and Vonoprazan Domperidone guide by Janus Biotech covers H. pylori eradication therapy, chronic GERD management, and why these combinations make a strong case for any gastro franchise portfolio. We also cover the Vonoprazan 10mg and 20mg tablet range available through Janus Biotech's PCD franchise model. If you're just joining us, Episode 2 covered Vonoprazan as a next-gen acid reflux treatment and Episode 3 broke down the Vonoprazan PCD franchise opportunity in detail.
    Mostra di più Mostra meno
    22 min
  • The Vonoprazan PCD Opportunity Nobody's Talking About - Janus Biotech

    The Vonoprazan PCD Opportunity Nobody's Talking About - Janus Biotech
    Jul 7 2026
    Episode 3. Vonoprazan is already gaining ground with doctors — but the real opportunity is on the distribution side. This episode breaks down why a Vonoprazan PCD pharma franchise makes business sense right now, from repeat demand driven by chronic GERD patients to monopoly rights and strong profit margins. We also cover the HP kit for H. pylori therapy and the Vonoprazan Domperidone combination — two products that round out a solid gastro portfolio. You can explore Vonoprazan 10mg and 20mg tablets directly on the Janus Biotech product page. If you missed the earlier episodes, Episode 2 covered Vonoprazan as a next-gen acid reflux treatment and Episode 1 explored the rise of niacinamide serum manufacturing in India.
    Mostra di più Mostra meno
    1 min
  • Vonoprazan The Next-Gen Acid Reflux Treatment-Janus Biotech

    Vonoprazan The Next-Gen Acid Reflux Treatment-Janus Biotech
    Jun 26 2026
    In Episode 2 of The Janus Pharma Insights, we explore Vonoprazan — a potassium-competitive acid blocker (P-CAB) offering fast, lasting relief for GERD, reflux esophagitis, and peptic ulcers. We look at why it's gaining traction with healthcare providers and how Janus Biotech supplies high-grade Vonoprazan 10 mg and 20 mg tablets to distributors and pharmacies across India. Looking for a reliable supply partner? Visit janus.co.in to learn more.
    🔗 Read more: https://janus.co.in/product/vonoprazan-20-mg-10mg/
    Mostra di più Mostra meno
    1 min
adbl_web_anon_alc_button_suppression_t1
Ancora nessuna recensione